1. Home
  2. PBHC vs AVXL Comparison

PBHC vs AVXL Comparison

Compare PBHC & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pathfinder Bancorp Inc. (MD)

PBHC

Pathfinder Bancorp Inc. (MD)

HOLD

Current Price

$16.72

Market Cap

108.9M

Sector

Finance

ML Signal

HOLD

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

BUY

Current Price

$1.33

Market Cap

115.9M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
PBHC
AVXL
Founded
1859
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
108.9M
115.9M
IPO Year
2014
2013

Fundamental Metrics

Financial Performance
Metric
PBHC
AVXL
Price
$16.72
$1.33
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.2K
★ 1.3M
Earning Date
11-06-2026
11-24-2026
Dividend Yield
★ 2.32%
N/A
EPS Growth
★ 46.25
N/A
EPS
★ 0.47
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$36.62
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.06
$1.14
52 Week High
$18.30
$8.79

Technical Indicators

Market Signals
Indicator
PBHC
AVXL
Relative Strength Index (RSI) 52.78 25.95
Support Level $15.48 N/A
Resistance Level $17.45 $1.60
Average True Range (ATR) 0.14 0.11
MACD -0.05 0.01
Stochastic Oscillator 63.99 30.70

Price Performance

Historical Comparison
PBHC
AVXL

About PBHC Pathfinder Bancorp Inc. (MD)

Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: